Arvinas
About:
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Website: http://www.arvinas.com
Twitter/X: arvinasinc
Top Investors: RA Capital Management, OrbiMed, Deerfield, Connecticut Innovations, RTW Investments
Description:
Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body.
$462M
$100M to $500M
New Haven, Connecticut, United States
2013-01-01
info(AT)arvinas.com
Craig M. Crews
251-500
2023-11-27
Public
© 2025 bioDAO.ai